Group One Trading
ROIV icon

Group One Trading’s Roivant Sciences ROIV Stock Holding History

Group One Trading’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.82M Sell
65,800
-30,700
-32% -$789K ﹤0.01% 2159
2025
Q4 		$2.09M Sell
96,500
-18,200
-16% -$359K ﹤0.01% 2250
2025
Q3 		$1.74M Buy
114,700
+21,700
+23% +$269K ﹤0.01% 2455
2025
Q2 		$1.05M Buy
93,000
+36,800
+65% +$399K ﹤0.01% 2723
2025
Q1 		$567K Buy
56,200
+33,900
+152% +$367K ﹤0.01% 2964
2024
Q4 		$264K Sell
22,300
-112,800
-83% -$1.33M ﹤0.01% 3712
2024
Q3 		$1.56M Buy
135,100
+46,300
+52% +$527K ﹤0.01% 1931
2024
Q2 		$939K Sell
88,800
-48,600
-35% -$533K ﹤0.01% 2037
2024
Q1 		$1.45M Sell
137,400
-9,500
-6% -$102K 0.01% 1761
2023
Q4 		$1.65M Sell
146,900
-573,700
-80% -$5.59M ﹤0.01% 2032
2023
Q3 		$8.42M Buy
720,600
+707,600
+5,443% +$8M 0.03% 616
2023
Q2 		$131K Sell
13,000
-16,600
-56% -$148K ﹤0.01% 4346
2023
Q1 		$218K Sell
29,600
-4,900
-14% -$40.3K ﹤0.01% 3585
2022
Q4 		$276K Buy
34,500
+21,000
+156% +$117K ﹤0.01% 3580
2022
Q3 		$43K Buy
+13,500
New +$52.3K ﹤0.01% 5525

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's ROIV Position: Q1 2026 in Review

Group One Trading opened a new position in Roivant Sciences (ROIV) in Q1 2026: 39,272 shares worth $1.09M. The stake represents ﹤0.01% of the portfolio and ranks #2628 among its holdings. This is a return to the name: Group One Trading previously reported a position in ROIV as recently as Q2 2025.

Group One Trading first reported a position in ROIV in Q3 2022 and has held it in 8 quarters since. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Group One Trading held 39,272 shares of Roivant Sciences worth $1.09M as of Q1 2026.
  • Roivant Sciences was a new Group One Trading position in Q1 2026.
  • Roivant Sciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2628 holding.
  • Group One Trading first reported a position in Roivant Sciences in Q3 2022 and has held it in 8 quarters since.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.